hematopoietic and lymphoid neoplasm project
DESCRIPTION
Hematopoietic and Lymphoid Neoplasm Project. Acknowledgments. American College of Surgeons (ACOS) Commission on Cancer (COC) Canadian Cancer Registries (CCR) National Cancer Registrars Association (NCRA) National Program of Cancer Registries (NPCR) of the Centers for Disease Control (CDC) - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/1.jpg)
Hematopoieticand Lymphoid NeoplasmProject
![Page 2: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/2.jpg)
Acknowledgments
• American College of Surgeons (ACOS) Commission on Cancer (COC)
• Canadian Cancer Registries (CCR)• National Cancer Registrars Association (NCRA)• National Program of Cancer Registries (NPCR) of
the Centers for Disease Control (CDC)• North American Association of Central Cancer
Registries (NAACCR)
2
![Page 3: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/3.jpg)
With Special Thanks to
• Graca Dores, MD• Charles Platz, MD• Amy Blum, RHIT, CTR• The Hematopoietic Working Group
3
![Page 4: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/4.jpg)
Moving Through the RulesPeggy Adamo, RHIT, CTRNCI SEEROctober 2009
![Page 5: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/5.jpg)
Four Questions
1. Is it reportable? 2. How many primaries do I abstract?3. How do I code the primary site and histology?4. How do I code the grade?
5
![Page 6: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/6.jpg)
Question 1
• Is it reportable?
6
![Page 7: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/7.jpg)
Case Reportability Instructions
• Go to the Case Reportability and Coding Manual
• Go through the 10 reportability instructions• If “No, not reportable” Stop• If “Yes, reportable” Continue
7
![Page 8: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/8.jpg)
Case Reportability Instructions
• Instruction 3 – ambiguous terms• For Reportability ONLY
8
![Page 9: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/9.jpg)
Instruction 10
Query the Hematopoietic DB to determine case reportability for special cases that do not meet the criteria listed in the above instructions
9
![Page 10: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/10.jpg)
Is it Reportable?
• If “No, not reportable” Stop• If “Yes, reportable” Continue to #2
10
![Page 11: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/11.jpg)
Question 2
• How many primaries do I abstract?
11
![Page 12: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/12.jpg)
Multiple Primary Rules
• Go to the Multiple Primary Rules in the manual
12
![Page 13: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/13.jpg)
Rule M10
Abstract as multiple primaries when a neoplasm is originally diagnosed in a chronic (less aggressive) phase AND second diagnosis of a blast or acute phase 21 days or more after the chronic diagnosis
13
![Page 14: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/14.jpg)
Rule M10 – use of database• Note 1: This is a change from previous rules.
Use the Hematopoietic DB to determine multiple primaries when a transformation from the chronic to a blast or acute phase occurs.
• Note 3: Transformations are defined in the Hematopoietic DB for each hematopoietic and lymphoid neoplasm.
14
![Page 15: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/15.jpg)
Rule M12
Abstract as multiple primaries when a neoplasm is originally diagnosed in the blast or acute phase and reverts to a less aggressive/chronic phase after treatment.
15
![Page 16: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/16.jpg)
Rule M12 – use of database
• Note 2: This is a change from previous rules. Use the Hematopoietic DB to determine multiple primaries when a transformation from the blast or acute phase to a chronic phase occurs.
• Note 3: Transformations are defined in the Hematopoietic DB for each hematopoietic and lymphoid neoplasm.
16
![Page 17: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/17.jpg)
Rule M13
Use the Hematopoietic DB to determine the number of primaries for all cases that do not meet the criteria of M1-M12
17
![Page 18: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/18.jpg)
Question 3
• How do I code the primary site and the histology of each primary?
18
![Page 19: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/19.jpg)
Primary Site andHistology Coding Rules
• Module 1: General Instructions• PH1• PH2 apply to all cases• PH3
19
![Page 20: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/20.jpg)
PH 2
Code the histology diagnosed by the definitive diagnostic method(s) (see Hematopoietic DB)…
20
![Page 21: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/21.jpg)
Modules 2 through 8
Module 2 Plasma Cell NeoplasmsModule 3 Lymphoma/LeukemiaModule 4 Preleukemia, Smoldering leukemia and
Myelodysplastic syndromeModule 5 Myeloid NeoplasmsModule 6 Specified LymphomaModule 7 Primary Site Rules for Lymphomas OnlyModule 8 Histology Rules Only: All hematopoietic
and lymphoid neoplasms
21
![Page 22: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/22.jpg)
Endnotes
• Go to the appropriate Module 2-8 • When Modules 2-8 do not apply to the case
being abstracted, go to Module 9
22
![Page 23: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/23.jpg)
Endnotes
• Module 1 2, 3, 4, 5, 6, 7, 8, or 9• Module 2 8• Module 3 8• Module 4 1, 7, or 8• Module 5 1, 7, or 8• Module 6 1, 7, or 8• Module 7 8• Module 8 9• Module 9 End of PH rules
23
![Page 24: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/24.jpg)
Rule PH40
• Use the Hematopoietic DB to determine the primary site and histology whenRules PH1-PH39 do not apply
24
![Page 25: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/25.jpg)
Question 4
• How do I code the grade for each primary?
25
![Page 26: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/26.jpg)
Grade of Tumor Rules
• Go to the Grade of Tumor Rules• Start with G1 and stop if this rule applies to
your case• If not, continue with G2 then go to the rule
that applies to your case
26
![Page 27: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/27.jpg)
Now what?
• Done!
27
![Page 28: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/28.jpg)
28
Moving Through the Rules
![Page 29: Hematopoietic and Lymphoid Neoplasm Project](https://reader036.vdocuments.us/reader036/viewer/2022062723/56813ff1550346895dab063c/html5/thumbnails/29.jpg)
Conclusion
• The new Hematopoietic and Lymphoid Neoplasm Rules go into effect for cases diagnosed January 1, 2010, and after
• Email address for questions [email protected]
29